동향
Home > DB > 동향
| New Drug Application (NDA) Process (CBER) | |||
|---|---|---|---|
| 분류 | New Drug | 조회 | 2407 |
| 발행년도 | 2010 | 등록일 | 2015-07-10 |
| 출처 | FDA (바로가기) | ||
|
Drug Master Files for CBER-Regulated Products
A Drug Master File (DMF) is a voluntary submission of confidential information to FDA about facilities, manufacturing, processing, packaging, and storing of one or more human drug products. (후략)
|
|||
|
|
 이전글 |
How Drugs are Developed and Approved |
|---|---|
 다음글 |
New Drug Applications (NDAs) |
